# Context Library Master Index

**Last Updated**: 2025-10-31  
**Total Contexts**: 1  
**Domains**: Oncology, Drug Development  
**Maintenance Schedule**: Review monthly, update on each addition

---

## How to Use This Index

### For AI Agents:
1. **Read this index first** to identify relevant context files
2. Check the "Use When" field to match your query
3. Load only the specific contexts needed
4. Follow related context links for comprehensive analysis

### Prompt Templates:

**Basic usage:**
```
Read the index at _INDEX.md, identify relevant contexts for [topic], 
then load and use them to answer: [your question]
```

**Specific context:**
```
Load oncology_lung_hnscc_development_patterns.md and analyze: [question]
```

**Multiple related contexts:**
```
Load oncology_lung_hnscc_development_patterns.md and all related contexts, 
then provide comprehensive analysis of: [question]
```

---

## Context Library Catalog

### üìÅ Oncology & Drug Development

#### **oncology_lung_hnscc_development_patterns.md**

**Full Title**: Sequential Development Patterns in Lung Cancer and Head-and-Neck Cancer Drug Development

**Purpose**: Framework for analyzing how pharmaceutical companies develop immunotherapy drugs across lung cancer and HNSCC indications

**Key Topics**:
- Sequential vs. parallel development strategies
- Clinical trial phase progression patterns
- Checkpoint inhibitor development
- Shared tumor biology (lung/HNSCC)
- Strategic decision-making frameworks
- Portfolio planning approaches

**Use When**:
- ‚úì Analyzing pipeline strategies for checkpoint inhibitors
- ‚úì Predicting clinical development timelines
- ‚úì Evaluating dual-indication strategies
- ‚úì Assessing competitive landscape in oncology
- ‚úì Supporting portfolio planning decisions
- ‚úì Investment analysis of oncology programs
- ‚úì Understanding why companies develop certain indications first

**Key Insights**:
- 89% of analyzed drugs pursue both lung and HNSCC indications
- Lung-first strategy dominates (larger market, faster enrollment)
- Shared biology (smoking-related, immunogenic) enables dual development
- Phase concordance indicates confidence level

**Data Coverage**:
- 9 drug development programs analyzed
- Phase I through Phase III data
- NSCLC, SCLC, and HNSCC indications

**Related Contexts**:
- immunotherapy_checkpoint_inhibitors.md *(placeholder - create next)*
- clinical_trial_phases.md *(placeholder - create next)*
- biomarker_strategies.md *(placeholder - create next)*

**Tags**: `clinical-trials`, `checkpoint-inhibitors`, `lung-cancer`, `HNSCC`, `sequential-development`, `immunotherapy`, `strategy`, `portfolio-planning`

**Confidence Level**: High  
**Version**: 1.0  
**Created**: 2025-10-31  
**Last Updated**: 2025-10-31  
**Word Count**: ~3,500  
**File Location**: `/mnt/user-data/outputs/oncology_lung_hnscc_development_patterns.md`

---

## Planned Context Files (Coming Soon)

### üìã High Priority
- [ ] **immunotherapy_checkpoint_inhibitors.md** - Technical overview of PD-1/PD-L1 mechanisms
- [ ] **clinical_trial_phases.md** - Detailed breakdown of Phase I/II/III requirements
- [ ] **biomarker_strategies.md** - TMB, PD-L1 testing approaches

### üìã Medium Priority
- [ ] **pharma_market_sizing_methodologies.md** - TAM/SAM/SOM frameworks
- [ ] **regulatory_fda_approval_pathways.md** - Oncology approval requirements
- [ ] **competitive_intelligence_frameworks.md** - Pipeline analysis methods

### üìã Lower Priority
- [ ] **pharmacokinetics_basics.md** - Drug PK/PD fundamentals
- [ ] **pricing_reimbursement_strategies.md** - Market access frameworks

---

## Domain Categories

Current domains in library:
1. **Oncology** (1 file)
2. **Drug Development** (1 file)
3. **Clinical Strategy** (1 file)

Future domains to add:
- Regulatory Affairs
- Market Analysis
- Technical/Scientific
- Commercial Strategy

---

## Index Maintenance Log

| Date | Action | Details |
|------|--------|---------|
| 2025-10-31 | Created index | Initial setup with first context file |
| 2025-10-31 | Added | oncology_lung_hnscc_development_patterns.md |

---

## Quick Search by Use Case

**Need help with:**
- **Portfolio planning** ‚Üí oncology_lung_hnscc_development_patterns.md
- **Competitive analysis** ‚Üí oncology_lung_hnscc_development_patterns.md
- **Timeline prediction** ‚Üí oncology_lung_hnscc_development_patterns.md
- **Investment analysis** ‚Üí oncology_lung_hnscc_development_patterns.md
- **Strategic planning** ‚Üí oncology_lung_hnscc_development_patterns.md

---

## Quick Search by Tag

- `#checkpoint-inhibitors` ‚Üí (1) oncology_lung_hnscc_development_patterns.md
- `#clinical-trials` ‚Üí (1) oncology_lung_hnscc_development_patterns.md
- `#lung-cancer` ‚Üí (1) oncology_lung_hnscc_development_patterns.md
- `#HNSCC` ‚Üí (1) oncology_lung_hnscc_development_patterns.md
- `#immunotherapy` ‚Üí (1) oncology_lung_hnscc_development_patterns.md
- `#strategy` ‚Üí (1) oncology_lung_hnscc_development_patterns.md

---

## Context Quality Standards

All context files in this library should meet these standards:

‚úì **Metadata header** with title, domain, tags, use cases, related contexts  
‚úì **Clear executive summary** at the beginning  
‚úì **Structured sections** with headers and subheadings  
‚úì **Actionable insights** for AI agent decision-making  
‚úì **Usage guidelines** explaining when to use the context  
‚úì **Version tracking** with created/updated dates  
‚úì **Related context links** for comprehensive analysis  
‚úì **Confidence levels** indicated for claims  
‚úì **Examples and frameworks** where applicable  

---

## File Naming Convention

**Format**: `[domain]_[topic]_[content-type].md`

**Examples**:
- ‚úì `oncology_lung_hnscc_development_patterns.md`
- ‚úì `immunotherapy_checkpoint_inhibitors_overview.md`
- ‚úì `clinical_trial_phases_reference.md`
- ‚úó `context1.md` (too generic)
- ‚úó `document.md` (not descriptive)

**Prefixes** (optional for categorization):
- `REF_` = Reference material
- `FWK_` = Frameworks
- `DATA_` = Data compilations
- `CASE_` = Case studies

---

## Version Control Notes

**Major version changes** (1.0 ‚Üí 2.0):
- Significant restructuring
- New sections added
- Changed conclusions

**Minor version changes** (1.0 ‚Üí 1.1):
- Updated data
- Minor corrections
- Added examples

**When to archive old versions**:
- Keep last 2 major versions
- Archive to `/contexts/archive/` folder

---

## Contact & Contribution

**Index Maintained By**: [Your Name/Team]  
**Last Review**: 2025-10-31  
**Next Review Due**: 2025-11-30

**To add new context**:
1. Create context file with metadata header
2. Add entry to this index
3. Update "Total Contexts" count
4. Add to relevant tag categories
5. Link to related contexts
6. Update maintenance log

---

**End of Master Index**
